ClinicalTrials.gg
Sign In

Hematoma clinical trials

The registry lists 109 studies for Hematoma across more than 10 countries. 19 are recruiting or about to start. 47 of them are mainly about Hematoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 3 narrower conditions too, such as Hematoma, Subdural, Chronic: 261 studies, 79 open.

Get an email when these change. Save the Hematoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
52
Status unknown
24
Recruiting
10
Terminated
8
Not yet recruiting
7
Withdrawn
5

Phase

Phase 4
16
Phase 3
4
Phase 2
3
Phase 1
2
Early Phase 1
1

Where

United States
25
China
10
Canada
9
France
5
Spain
5
Turkey
5

Who runs them

Ottawa Heart Institute Research Corporation (3) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio (2) · VA Long Beach Healthcare System (2) · Total Definer Research Group (2) · University of British Columbia (2) · Nanchong Central Hospital (2) · Kanuni Sultan Suleyman Training and Research Hospital (2) · First Affiliated Hospital of Zhejiang University (2)

What is being tested here

Drugs under test in Hematoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Aspirin101
Enoxaparin101
Tranexamic Acid016
Dabigatran011
Rivaroxaban011
Apixaban011
Fibrin Tissue Adhesive001
Platelet rich plasma011
Warfarin001
PF-05230907001

Coming up

0phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 10 Hematoma studies recruiting now, 9 (90%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (20%) take children under 18. 2 (20%) are for women only and 0 (0%) for men only; 3 (30%) take healthy volunteers.

Recruiting studies that take each age, of 10
AgeWomenMen
102 (20%)2 (20%)
1810 (100%)8 (80%)
3010 (100%)8 (80%)
4010 (100%)8 (80%)
5010 (100%)8 (80%)
6510 (100%)8 (80%)
7510 (100%)8 (80%)
8510 (100%)8 (80%)

Across all 109 studies, recruiting or not: 17% stop at 75 or younger and 15% at 65; 13% take children; 19% are for women only and 4% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hematoma studies take

Of 34 interventional studies with no phase under Hematoma, half reached primary completion within 15 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase15 mo6–36 · 34 studies—15 mo6–36 · 30 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 109. Browse all 109 → or search them.